TERMIS Webinar: “Biopreservation: Cryopreservation and Non-Frozen Storage for GMP Regenerative Medicine.”

Print Friendly

Thursday, August 7th – Aby J. Mathew PhD, BioLife Solutions Inc.

Webinar announcement from Chris Gemmiti, PhD, TERMIS

Please join me for our next Commercialization TWIG webinar on Thursday August 7th at 12PM PDT / 3PM EDT, where Aby J. Mathew PhD, Senior Vice President & Chief Technology Officer of BioLife Solutions Inc will be presenting “Biopreservation: Cryopreservation and Non-Frozen Storage for GMP Regenerative Medicine.” The presentation will last about 30 minutes, with ample time for Q&A.

Attendance is limited to 25, and you must register in advance so that I can send you the password. Registering takes less than one minute and can be done here:
https://www.surveymonkey.com/s/GPZ5FL5

TERMIS (Tissue Engineering and Regenerative Medicine International Society) is an international learned society. Its goal is the worldwide advancement of both the science and technology of tissue engineering and regenerative medicine. The Society promotes education and research within the field of tissue engineering and regenerative medicine through regular meetings, publications and other forms of communication. The Society also serves as an international forum to promote the informed discussion of challenges and therapeutic benefits of the application of tissue engineering and regenerative medicine technologies.

Stem Cells & Regenerative Medicine Congress 2014

Print Friendly

The Westin Copley Place, Boston
September 15-16, 2014

The 6th annual Stem Cells & Regenerative Medicine Congress is North America’s leading commercial stem cells event for biotechs, academia, government and CMOs to talk about process enhancement, innovative technology and business development.

From regulation, approaches to alternative regenerative medicine, and the latest exciting developments in iPS cells, the Congress provides opportunities and strategies for biotechs and their partners. This event is co-located with World Cord Blood Congress 2014.

Please visit BioLife Solutions @ Booth #19.

Go to Event Site

IBC’s 4th Annual Cell Therapy Bioprocessing Conference

Print Friendly

September 15-16, 2014
Sheraton Pentagon City Hotel, Arlington, VA

IBC’s Cell Therapy Bioprocessing conference has a reputation of providing a first-rate faculty of participants, who collectively share perspectives and lessons learned from detailed case studies to help overcome challenges, develop strategies and implement technologies to propel this field towards commercial sustainability. This meeting continues to serve as a bridge to help companies move their cell therapies from laboratory to commercial scale because it is committed to establishing cell therapies as a viable and profitable industry.

Aby J. Mathew, Ph.D., Senior Vice President & Chief Technology Officer, BioLife Solutions, Inc. will present Biopreservation and Biologistics – Points of Risk in the Cell/Tissue Life Cycle during the BioLife sponsored Biopreservation and Product Stability Considerations for GMP Session on September 16th.

Go to Event Site

2nd BioLogistics Summit

Print Friendly

DoubleTree by Hilton Hotel, Mission Valley
San Diego, CA

June 16-18, 2014

The 2nd BioLogistics Summit will tackle the key challenges associated with the handling, storing, manufacturing and distribution of biologics.

BioLife Solutions’ President and CEO, Mike Rice, will present “Intelligent, Informed, Precise Clinical Materials Management” during the 2:00 PM session on Day 1 of the main conference (June 17th). In addition, BioLife will host the official Networking Drinks Reception, 5:00-6:30 PM, following the close of Day 1. Attendees may also visit with BioLife representatives in Booth 8 during exhibition hours.

Go to Event Site

12th International Cord Blood Symposium

Print Friendly

June 5-7, 2014
Hyatt Regency, San Francisco

The 12th International Cord Blood Symposium is the premier event bringing together leaders and experts in the areas of Stem Cell Transplantation, Regenerative Medicine, Cellular Therapies, and Cord Blood Banking. The scientific program will provide the most up-to-date advancements in these areas, with the vision that education will support future advancement.

Please visit with BioLife Solutions representatives at Booths 202 & 204 to see the newest biopreservation tools in our product line.

Go to Event Site

CRYO 2014 – World Forum on Biology

Print Friendly

Savannah, GA
May 31-June 4, 2014

The Society for Cryobiology and The Society for In Vitro Biology welcome you to participate in the 2014 World Forum on Biology which will be held from May 31 – June 4, 2014 in Savannah, Georgia at the Hyatt Regency Savannah. This will be the first time that SIVB and SfC have joined their scientific efforts and you won’t want to miss this exciting collaboration! This international meeting’s program will focus on both plant and animal cryobiology, cell culture and biotechnology.

BioLife’s Chief Technology Officer, Dr. Aby J. Mathew, will chair Session 6, Titled: Are Cryobiologists and Everyone Else Speaking Different Languages? – Bridging the GMP/Biobanking/Clinical Gap. This session is intended to facilitate discussion between non-cryobiologists that seek improved methods for biopreservation of cells/tissues for clinical/biobanking/manufacturing applications, and cryobiologists who focus on the science of biopreservation.

Go to Event Site

ISBER 2014 Annual Meeting

Print Friendly

May 20-24, 2014
Orlando, Florida

The ISBER 2014 Annual Meeting theme is ‘Fact not Fantasy: Evidence-Based Biobanking’. The Meeting will highlight unique and interdisciplinary best practices of both human and environmental repositories with regard to sample integrity, availability, interrogation and reliability of results. These explorations will accelerate the biobanking community toward improved repository management, leading to better scientific decisions and enhanced global and environmental health.

The program will feature five symposia, four contributed paper sessions, pre-conference workshops, special topic sessions, interactive discussions and poster sessions. Delegates can expect to exchange ideas, learn about new breakthroughs, and interact with colleagues in the global biobanking community.

Visit with BioLife Solutions representatives in Booth 215a.

Go to Event Site.

ARM’s Regen Med Investor Day

Print Friendly

RMDay2_Web_Banner_580

March 26, 2014
New York, New York

The Alliance for Regenerative Medicine in partnership with Maxim Group and Piper Jaffray will host a one-day, high impact program providing institutional, strategic and venture investors with unique insight into the financing hypothesis for regenerative medicine and advanced therapies-based treatment and tools. The event includes clinical and commercial experts who are on-hand to address specific questions regarding the outlook for these products, as well as offer insight into how regen med could impact the standard of care in key therapeutic areas such as cardiovascular disease, wound healing and tissue repair, ophthalmology, neurodegenerative diseases, diabetes and oncology. The program will include talks by key opinion leaders in the industry, life science investment experts and analysts covering the sector as well as presentations by more than 30 leading companies from across the globe.

Go to Event Site

20th ISCT Annual Meeting

Print Friendly
The 20th Annual Meeting will be held at Le Palais des Congrès de Paris in Paris, France. Over 1,000 international delegates are expected to be in attendance including: ISCT 2014
  • MD and/or PhD clinicians and scientists
  • Laboratory professionals involved in cell-processing programs/facilities
  • Industry personnel from cell therapy or enabling technology companies
  • Regulatory experts

BioLife Solutions’, Dr. Aby J. Mathew, will co-chair Strategies for Commercialization Track 3, co-sponsored with Society for Cryobiology – Cryopreservation and Biopreservation: innovations supporting product supply and logistics; April 24th, 3:30 pm, Amphitheatre Havane.

Visit with BioLife Solutions representatives in Booth 1-2.

Go to Event Site

Future Biotech Summit/Cell & Gene Therapy

Print Friendly

February 20-21, 2014

San Diego, CA

Treatment of disease using cell and gene therapy is now a reality. With emerging technologies and new clinical trials being developed and launched at a growing rate, this meeting will discuss the evolving regulatory challenges and pre-clinical requirements, the development and applications of cell and gene therapy, immune responses, as well as business model and commercial milestones.

Aby J. Mathew, Senior Vice President & Chief Technology Officer, BioLife Solutions, Inc., will present Best Practices in Stability/Biopreservation for Cell & Tissue Bioprocessing, Clinical Development, and Patient Delivery during the Strategies for Commercialization session on Friday, February 21st.

Go to Event Site